Delivery Order SPE2DB20D3104-SPE2DB25FV8U8
Award Date 7/11/25
Potential Completion Date 7/14/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,828.20 to AmerisourceBergen Drug Corp for HAVRIX 720 Unit/0.5 ML syringes. The contract is a firm fixed price delivery order with no set-aside designation, awarded on May 27, 2025, with an ultimate completion date of May 28, 2025. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,619.52 delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of HAVRIX 720 Unit/0.5 ML syringes. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility, with an...
- The Defense Logistics Agency awarded a $8,097.60 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Havrix 720 Unit/0.5 mL syringes. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by August 12, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,597.88 to AmerisourceBergen Drug Corp for 1,440 units/mL of Havrix vaccine in syringes. The contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, utilizes a firm fixed price structure with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,136.36 for 1,440 units/mL of HAVRIX vaccine syringes on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a single transaction under the company's larger pharmaceutical supply relationship...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,490.36 to AmerisourceBergen Drug Corp for the supply of HAVRIX 1,440 Unit/ML vaccine syringes. This competitively awarded, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of HAVRIX 1,440 Unit/ML Syringe vaccines valued at $1,339.10. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The order is scheduled for completion by August 7, 2025, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,523.83 to AmerisourceBergen Drug Corp for the supply of 1,440 units of Havrix vaccine (1 ml syringes) with a completion date of June 30, 2025. This firm fixed-price contract, awarded on June 27, 2025, with no set-aside designation, will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a competitive award to a critical pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for 1,440 units of Havrix 1-unit/mL vaccine syringes, valued at $6,200.90 under a firm fixed-price contract type. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 billion through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Havrix 720 Unit/0.5 ML syringes valued at $5,671.48 with a firm fixed price structure. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support...